In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite
Somayeh Sadeghi, Negar Seyed, Mohammad-Hossein Etemadzadeh, Saeid Abediankenari, Sima Rafati, Tahereh Taheri
Korean J Parasito. 2015;53(4):385-394.   Published online 2015 Aug 25     DOI: https://doi.org/10.3347/kjp.2015.53.4.385
Citations to this article as recorded by Crossref logo
Insights into the drug screening approaches in leishmaniasis
Boobalan Gopu, Parampreet Kour, Ramajayan Pandian, Kuljit Singh
International Immunopharmacology.2023; 114: 109591.     CrossRef
A short-term method to evaluate anti-leishmania drugs by inhibition of stage differentiation in Leishmania mexicana using flow cytometry
Christian Florian Teh-Poot, Victor Manuel Dzul-Huchim, Jonathan M. Mercado, Liliana Estefanía Villanueva-Lizama, Maria Elena Bottazzi, Kathryn M. Jones, Francis T.F. Tsai, Julio Vladimir Cruz-Chan
Experimental Parasitology.2023; 249: 108519.     CrossRef
Challenges and Tools for In Vitro Leishmania Exploratory Screening in the Drug Development Process: An Updated Review
Anita Cohen, Nadine Azas
Pathogens.2021; 10(12): 1608.     CrossRef
A survey on inhibitory effect of whole-body extraction and secretions of Lucilia sericata's Larvae on Leishmania major In vitro
Maryam Tahmasebi, Simindokht Soleimanifard, Alireza Sanei, Azadeh Karimy, SeyedMohammad Abtahi
Advanced Biomedical Research.2020; 9(1): 12.     CrossRef
Potential of the natural products against leishmaniasis in Old World - a review of in-vitro studies
Sofia Cortes, Carolina Bruno de Sousa, Thiago Morais, João Lago, Lenea Campino
Pathogens and Global Health.2020; 114(4): 170.     CrossRef
Sambucus ebulus extract stimulates cellular responses in cutaneous leishmaniasis
Maryam Heidari‐Kharaji, Vahid Fallah‐Omrani, Alireza Badirzadeh, Behnam Mohammadi‐Ghalehbin, Mohammad Ali Nilforoushzadeh, Leila Masoori, Hossein Montakhab‐Yeganeh, Mehrak Zare
Parasite Immunology.2019;[Epub]     CrossRef
In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates
Sarah Hendrickx, Lieselotte Van Bockstal, Guy Caljon, Louis Maes, Kiyoshi Kita
PLOS Neglected Tropical Diseases.2019; 13(12): e0007885.     CrossRef
Assessment of Leishmania cell lines expressing high levels of beta-galactosidase as alternative tools for the evaluation of anti-leishmanial drug activity
Aline C. da Silva Santos, Danielle M.N. Moura, Thiago A.R. dos Santos, Osvaldo P. de Melo Neto, Valéria R.A. Pereira
Journal of Microbiological Methods.2019; 166: 105732.     CrossRef
Development of NanoLuc-PEST expressing Leishmania mexicana as a new drug discovery tool for axenic- and intramacrophage-based assays
Sarah L. Berry, Hamza Hameed, Anna Thomason, Marissa L. Maciej-Hulme, Somaia Saif Abou-Akkada, Paul Horrocks, Helen P. Price, Timothy G. Geary
PLOS Neglected Tropical Diseases.2018; 12(7): e0006639.     CrossRef
Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites
Alireza Badirzadeh, Tahereh Taheri, Yasaman Taslimi, Zahra Abdossamadi, Maryam Heidari-Kharaji, Elham Gholami, Baharehsadat Sedaghat, Maryam Niyyati, Sima Rafati, Armando Jardim
PLOS Neglected Tropical Diseases.2017; 11(7): e0005774.     CrossRef
Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice
Zahra Abdossamadi, Negar Seyed, Farnaz Zahedifard, Tahereh Taheri, Yasaman Taslimi, Hossein Montakhab-Yeganeh, Alireza Badirzadeh, Mohammad Vasei, Safoora Gharibzadeh, Sima Rafati, Michael P. Pollastri
PLOS Neglected Tropical Diseases.2017; 11(12): e0006123.     CrossRef
EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice
Samira Seif, Fereshteh Kazemi, Elham Gholami, Negar Seyed, Yasaman Taslimi, Sima Habibzadeh, Bahareh Azarian, Shahram Jamshidi, Mehrdad Hashemi, Sima Rafati, Tahereh Taheri
Applied Microbiology and Biotechnology.2016; 100(9): 3923.     CrossRef